MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation-Reference-Cited by-同舟云学术

MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation

Published:2017-04-12 Issue:1 Volume:11 Page:120-130
ISSN:1933-0219
Container-title:Mucosal Immunology
language:en
Short-container-title:Mucosal Immunol

Author:

Ho G-T,Aird R E,Liu B,Boyapati R K,Kennedy N A,Dorward D A,Noble C L,Shimizu T,Carter R N,Chew E T S,Morton N M,Rossi A G,Sartor R B,Iredale J P,Satsangi J

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/mi201731.pdf

Reference68 articles.

1. Danese, S. & Fiocchi, C. Ulcerative colitis. N Engl J Medicine 365, 1713–1725 (2011).

2. Boyapati, R., Satsangi, J. & Ho, G.T. Pathogenesis of Crohn's disease. F1000Prime Rep 7, 44 (2015).

3. Molodecky, N.A. et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46–54, e42 quiz e30 (2012).

4. Ho, G.-T., Boyapati, R. & Satsangi, J. Ulcerative colitis. Medicine 43, 276–281 (2015).

5. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124 (2012).

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging role of oxidative stress in inflammatory bowel disease;Frontiers in Endocrinology;2024-07-15

2. Precision therapy for ulcerative colitis: insights from mitochondrial dysfunction interacting with the immune microenvironment;Frontiers in Immunology;2024-07-04

3. Molecular targets associated with ulcerative colitis and the benefits of atractylenolides-based therapy;Frontiers in Pharmacology;2024-05-27

4. Mitochondrial function and gastrointestinal diseases;Nature Reviews Gastroenterology & Hepatology;2024-05-13

5. Potential mitigating impact of a dipeptidyl peptidase-IV inhibitor, vildagliptin, on oxazolone-induced ulcerative colitis: Targeting the role of PI3K/AKT/mTOR and AMPK/Nrf2 signaling pathways;International Immunopharmacology;2024-05